NCT04651816

Brief Summary

This initiative, which is a partnership between State College area Penn State Health ambulatory care clinics located off campus in the State College area, has two primary goals: 1) improve the health and quality of life of Penn State Health patients with pre-diabetes and 2) decrease associated health care costs due to type 2 diabetes and its complications. The results from the study may serve as a model for additional chronic disease prevention programs to implement in additional Penn State Health clinics in the future.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 3, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

May 25, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 8, 2023

Completed
Last Updated

September 5, 2023

Status Verified

September 1, 2023

Enrollment Period

2.2 years

First QC Date

November 24, 2020

Last Update Submit

September 1, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Weight Loss

    Patients will be monitored through out the study for healthy weight loss.

    12 months

  • Subject Retention

    Participants will be tracked for retention throughout the study.

    12 months

Secondary Outcomes (7)

  • Blood Pressure

    12 months

  • A1c

    12 months

  • Total Cholesterol

    12 months

  • Pregnancy Status

    12 months

  • Knee Injury and Osteoarthritis Outcome Score (KOOS)

    12 months

  • +2 more secondary outcomes

Study Arms (4)

Control PSH DPP only

ACTIVE COMPARATOR

This group will be enrolled the PSH DPP program. There will be two cohorts for this arm.

Behavioral: DPP Program

Treatment 1 Financial Incentives A

EXPERIMENTAL

This group will receive gift cards as financial incentive to participate in the PSH DPP program. There will be two cohorts for this arm.

Behavioral: Financial IncentivesBehavioral: DPP Program

Treatment 2 Financial Incentives B

EXPERIMENTAL

This group will receive gift cards as financial incentive to participate in the PSH DPP program. There will be two cohorts for this arm.

Behavioral: Financial IncentivesBehavioral: DPP Program

Treatment 3 Motivational Text Messaging

EXPERIMENTAL

This group will receive text messages with motivational messages while participating in the PSH DPP program. There will be two cohorts for this arm.

Behavioral: Motivational MessageBehavioral: DPP Program

Interventions

Participants will be entered into a lottery to receive a gift card for class attendance.

Treatment 1 Financial Incentives ATreatment 2 Financial Incentives B

Participants will be sent motivational messages through out their participation in the PSH DPP program.

Treatment 3 Motivational Text Messaging
DPP ProgramBEHAVIORAL

All Participants will be enrolled in the DPP program.

Control PSH DPP onlyTreatment 1 Financial Incentives ATreatment 2 Financial Incentives BTreatment 3 Motivational Text Messaging

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Be at least 18 years old and under age 65 AND
  • Body Mass Index ≥25 kg/m2 (≥23 kg/m2 if Asian) AND
  • Not be pregnant at time of enrollment AND
  • Have no previous diagnosis of type 1 or type 2 diabetes AND
  • Have a blood test result in the prediabetes range within the past year, meeting one of these specifications:
  • Hemoglobin A1c: 5.7-6.4%, OR
  • Fasting plasma glucose : 100-125 mg/dL, OR
  • Two-hour plasma glucose (after a 75-gm glucose load): 140-199 mg/dL, OR
  • Have a previous clinical diagnosis of gestational diabetes mellitus (GDM), AND
  • Not in hypertensive crisis with systolic over 180 and/or diastolic over 120
  • Be an established patient at a Penn State Health clinic in State College, PA (i.e. have at least one visit in past 18 months) AND
  • Fluent in English AND
  • Own and carry an iPhone (running iOS version 10 or higher) or Android (running operating system 7 or higher) smartphone during waking hours
  • Internet access
  • Tablet or desktop/laptop computer with webcam for classes
  • +1 more criteria

You may not qualify if:

  • Under 18 years old and over age 65
  • Body Mass Index \<25 kg/m2 (\<23 kg/m2 if Asian)
  • Pregnant at the time of enrollment
  • Previous diagnosis of type 1 or type 2 diabetes
  • Have a blood test result within the past year meeting one of these specifications:
  • Hemoglobin A1c: not in range of 5.7-6.4%
  • Fasting plasma glucose: not in range of 100-125 mg/dL
  • Two-hour plasma glucose (after a 75-gm glucose load): not in range of 140-199 mg/dL
  • No previous clinical diagnosis of gestational diabetes
  • Active hypertensive crisis with systolic over 180 and/or diastolic over 120 (patients in this category would be referred to primary care provider for immediate visit)
  • Not be an established patient at a Penn State Health clinic in State College, PA (i.e. have not had at least one visit in the past 18 months)
  • Not fluent in English
  • Not own and carry an iPhone (running iOS version 10 or higher) or Android (running operating system 7 or higher) smartphone during waking hours.
  • Decisional impairment
  • Prisoner status
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State Health Medical Group -- Park Avenue

State College, Pennsylvania, 16803, United States

Location

MeSH Terms

Conditions

Glucose Intolerance

Condition Hierarchy (Ancestors)

HyperglycemiaGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not know what intervention group they will be assigned to (motivational messaging, incentives or control group).
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Distinguished Professor of Health Policy and Administration, Director of the Center for Health Care and Policy Research

Study Record Dates

First Submitted

November 24, 2020

First Posted

December 3, 2020

Study Start

May 25, 2021

Primary Completion

August 8, 2023

Study Completion

August 8, 2023

Last Updated

September 5, 2023

Record last verified: 2023-09

Locations